Researchers from the International Agency for Research on Cancer (IARC) provide comprehensive global, regional, and national estimates of alcohol-attributable cancer burden in 2020.
Long-established links connect alcohol consumption to cancers of the breast, liver, colon, rectum, oropharynx, larynx, esophagus, and throat. While prior estimates exist, shifting drinking patterns worldwide—such as declining per capita intake in Europe and rising levels in Asia and sub-Saharan Africa—necessitate updated figures.
"New estimates of the cancer burden attributable to alcohol are warranted," stresses Harriet Rumgay, PhD, from IARC in France.
Rumgay and her team analyzed 2010 consumption data (drawn from tax and sales records) alongside well-established alcohol-related cancer risk estimates, accounting for the latency period between exposure and diagnosis.
"There is a delay between alcohol consumption and potential cancer development, requiring a latency adjustment between exposure year and diagnosis," explains Dr. Rumgay.
They integrated these with pre-pandemic 2020 cancer incidence data to avoid COVID-19 disruptions, estimating alcohol-attributable cases.
Findings reveal alcohol caused about 568,700 cancer cases in men and 172,600 in women in 2020—over 740,000 total. Esophageal, liver, and breast cancers predominated.
Notably, while heavy drinking drives most cases, even low-to-moderate intake (≤10g/day, like one beer or small wine) contributed to 35,400–145,800 global cases.
Regional variations were stark: lower proportions in North Africa and West Asia, higher in East Asia and Central/Eastern Europe. Future work will quantify alcohol-related cancer deaths.
Authorities should amplify awareness of alcohol-cancer links, urge Dr. Rumgay's team.
"Alcohol's cancer impact is often underrecognized. We need public education and policies like warning labels and higher taxes to curb consumption and prevent cancers and other diseases," she concludes.
